<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30340621</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>20</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1752-1947</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>12</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>20</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of medical case reports</Title>                <ISOAbbreviation>J Med Case Rep</ISOAbbreviation>            </Journal>            <ArticleTitle>Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report.</ArticleTitle>            <Pagination>                <MedlinePgn>301</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13256-018-1843-4</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The incidence of superior vena cava syndrome within the United States is roughly 15,000 cases per year. Superior vena cava syndrome is a potentially life-threatening medical condition; however, superior vena cava syndrome is not fatal in the majority of cases. Superior vena cava syndrome encompasses a collection of signs and symptoms resulting from obstruction of the superior vena cava, including swelling of the upper body of the head, neck, arms, and/or breast. It is also associated with cyanosis, plethora, and distended subcutaneous vessels. Lung cancer, including both non-small cell lung cancer and small cell lung cancer, is the most common extrinsic cause of superior vena cava syndrome. Intrinsic disruption of superior vena cava flow can also precipitate superior vena cava syndrome. This case report describes an unusual presentation and potential etiology of superior vena cava syndrome.</AbstractText>                <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">Our patient was a 51-year-old black woman with locally advanced, stage IIIB non-small cell lung cancer who had no clinical symptoms of superior vena cava syndrome at the time of diagnosis. However, she did have radiographic evidence of superior vena cava stenosis caused by extrinsic compression from her large right hilar primary tumor. She was treated with definitive chemoradiation, receiving 60Â Gy of external beam radiation therapy given concurrently with chemotherapy. Three months after completion of radiotherapy, she developed signs of superior vena cava syndrome, including breast and supraclavicular swelling. She had a chest computed tomography scan showing over 50% reduction in the size of a right hilar mass; however, she had continued radiographic stenosis of the superior vena cava. The distribution of stenosis appeared to be inferior to the caudal extent of pretreatment tumor volume. She had no other radiographic indications for superior vena cava syndrome.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Generally, superior vena cava syndrome is the result of extrinsic compression of the superior vena cava by tumor. Our patient's case represents the development of superior vena cava syndrome after an excellent response of tumor with near-complete tumor response. We suspect chemoradiation therapy as a potential etiology for the precipitation of the superior vena cava syndrome, which is currently not well reported in the medical literature.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Hinton</LastName>                    <ForeName>Jason</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Indiana University School of Medicine, 535 Barnhill Drive, Cancer Care Pavilion 041, Indianapolis, IN, 46202-5289, USA. hintonja@iu.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cerra-Franco</LastName>                    <ForeName>Alberto</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Indiana University School of Medicine, 535 Barnhill Drive, Cancer Care Pavilion 041, Indianapolis, IN, 46202-5289, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shiue</LastName>                    <ForeName>Kevin</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Indiana University School of Medicine, 535 Barnhill Drive, Cancer Care Pavilion 041, Indianapolis, IN, 46202-5289, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shea</LastName>                    <ForeName>Lindsey</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Indiana University School of Medicine, 550 North University Boulevard, Room 0663, Indianapolis, IN, 46202, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aaron</LastName>                    <ForeName>Vasantha</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Indiana University School of Medicine, 550 North University Boulevard, Room 0663, Indianapolis, IN, 46202, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Billows</LastName>                    <ForeName>Geoffrey</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Emergency Medicine, Indiana University School of Medicine, 720 Eskenazi Avenue, Fifth Third Bank Building 3rd Floor, Indianapolis, IN, 46202, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Al-Hader</LastName>                    <ForeName>Ahmad</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Hematology and Oncology, Indiana University School of Medicine, 980 West Walnut Street R3 C312, Indianapolis, IN, 46202, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lautenschlaeger</LastName>                    <ForeName>Tim</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Indiana University School of Medicine, 535 Barnhill Drive, Cancer Care Pavilion 041, Indianapolis, IN, 46202-5289, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>20</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>J Med Case Rep</MedlineTA>            <NlmUniqueID>101293382</NlmUniqueID>            <ISSNLinking>1752-1947</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Radiation-induced SVC syndrome</Keyword>            <Keyword MajorTopicYN="N">SVC syndrome</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30340621</ArticleId>            <ArticleId IdType="doi">10.1186/s13256-018-1843-4</ArticleId>            <ArticleId IdType="pii">10.1186/s13256-018-1843-4</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>